ClinicalTrials.govpublic full text
Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial
type 2 diabetes
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 303695
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.